Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTRL
3901
PUT
DELISTED
Control4 Corporation
CTRL
| $1.47M | ﹤0.01% |
49,500
+14,500
| +41% | +$450K |
|
3902
iShares Global Utilities ETF
JXI
$308M
| $1.47M | ﹤0.01% |
+29,718
| New | +$1.53M |
|
|
ABB
3903
CALL
DELISTED
ABB Ltd
ABB
| $1.47M | ﹤0.01% |
54,900
+22,400
| +69% | +$575K |
|
3904
CALL
Henry Schein
HSIC
$10B
| $1.47M | ﹤0.01% |
26,775
-893
| -3% | -$51.8K |
|
3905
PUT
Wendy's
WEN
$1.65B
| $1.47M | ﹤0.01% |
89,200
+67,300
| +307% | +$1.02M |
|
|
KEM
3906
CALL
DELISTED
KEMET Corporation
KEM
| $1.46M | ﹤0.01% |
97,200
+36,900
| +61% | +$703K |
|
3907
PUT
Ecolab
ECL
$77.4B
| $1.46M | ﹤0.01% |
10,900
-17,800
| -62% | -$2.37M |
|
3908
CALL
ProShares UltraPro Dow 30
UDOW
$924M
| $1.46M | ﹤0.01% |
62,000
+44,000
| +244% | +$912K |
|
3909
CALL
Cadence Design Systems
CDNS
$89.5B
| $1.46M | ﹤0.01% |
34,900
-26,600
| -43% | -$1.14M |
|
|
FINL
3910
PUT
DELISTED
Finish Line
FINL
| $1.46M | ﹤0.01% |
100,400
-25,300
| -20% | -$273K |
|
3911
Interparfums
IPAR
$3.67B
| $1.46M | ﹤0.01% |
+33,552
| New | +$1.46M |
|
3912
Brighthouse Financial
BHF
$3.37B
| $1.46M | ﹤0.01% |
24,831
+10,971
| +79% | +$649K |
|
3913
CALL
WIX.com
WIX
$3.1B
| $1.46M | ﹤0.01% |
25,300
-3,600
| -12% | -$223K |
|
3914
Northwest Bancshares
NWBI
$2.31B
| $1.45M | ﹤0.01% |
86,898
-99,386
| -53% | -$1.67M |
|
3915
PUT
Cenovus Energy
CVE
$57.2B
| $1.45M | ﹤0.01% |
159,200
+98,600
| +163% | +$958K |
|
3916
CALL
Puma Biotechnology
PBYI
$456M
| $1.45M | ﹤0.01% |
14,700
-10,600
| -42% | -$1.19M |
|
3917
Companhia Siderúrgica Nacional
SID
$1.17B
| $1.45M | ﹤0.01% |
592,544
+579,149
| +4,324% | +$1.49M |
|
3918
PUT
iShares MSCI Turkey ETF
TUR
$222M
| $1.45M | ﹤0.01% |
33,400
+7,100
| +27% | +$290K |
|
|
NETI
3919
DELISTED
Eneti Inc.
NETI
| $1.45M | ﹤0.01% |
21,100
-1,795
| -8% | -$125K |
|
3920
Commerce Bancshares
CBSH
$8.64B
| $1.45M | ﹤0.01% |
38,362
+18,136
| +90% | +$676K |
|
3921
PUT
MSC Industrial Direct
MSM
$6.91B
| $1.45M | ﹤0.01% |
15,000
+8,400
| +127% | +$702K |
|
3922
CALL
Cal-Maine
CALM
$3.8B
| $1.45M | ﹤0.01% |
32,600
-11,200
| -26% | -$499K |
|
|
ONCE
3923
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.45M | ﹤0.01% |
28,184
+14,561
| +107% | +$1.05M |
|
3924
CALL
Ollie's Bargain Outlet
OLLI
$4.62B
| $1.45M | ﹤0.01% |
27,200
+5,600
| +26% | +$264K |
|
3925
State Street SPDR Portfolio Europe ETF
SPEU
$743M
| $1.45M | ﹤0.01% |
40,292
-26,618
| -40% | -$946K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.